|
Mar 18
|
Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates
|
|
Mar 18
|
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
|
|
Mar 8
|
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
|
|
Mar 7
|
Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
|
|
Feb 6
|
Despite Fast-paced Momentum, Exagen Inc. (XGN) Is Still a Bargain Stock
|
|
Jan 7
|
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
|
|
Aug 9
|
Exagen Inc. (NASDAQ:XGN) Q2 2023 Earnings Call Transcript
|
|
Aug 8
|
Q2 2023 Exagen Inc Earnings Call
|
|
Aug 7
|
Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 7
|
Exagen Inc. Reports Strong Second Quarter 2023 Results
|
|
May 1
|
Exagen Announces Campaign for Lupus Awareness Month
|